NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/06/2024
Back to search
Official data from USPTO
BIOSS ANTIBODIES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
09/06/2024
Trademark type
Combined
Nice classes
1
Filing date
07/05/2017
Registration date
02/27/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/06/2024
Last transaction
09/06/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
06/30/2014
First use in commerce
06/30/2014
Drawing code
3
Owner type
03
Owner location
Woburn, MA
Examiner
KELLY, JOHN
Current location
FILE DESTROYED
Mark description
The mark consists of the word "Bioss" above the word "ANTIBODIES", where the letter "O" in "Bioss" has three branches extending from its outer surface with a solid circle at the end of each branch, and where one such circle forms the dot of the letter "i" in "Bioss" and another such circle forms the "O" in the word "ANTIBODIES".
Holders and representatives
Holders
Bioss Inc.
Representatives
Mark A. Wright MCLANE MIDDLETON, PROFESSIONAL ASSOCIATION
Technical classification
Nice Classes
Class 1
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biochemical reagents commonly known as probesfor detecting and analyzing molecules in protein or nucleotide arrays; Biochemical reagents used for non-medical purposes; Biochemicalsmonoclonal antibodies for in vitro scientific or research use; Biochemicalspolypeptides for in vitro research use; Biomedical compoundspeptide substrates used in analyzing and detecting certain toxins for laboratory or research use; Chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with amplificationanalysis or labeling of nucleic acid; Chemicals for use in the purification of proteins for in vitro use; Diagnostic preparations for scientific or research use; Diagnostic reagents for in vitro use in biochemistryclinical chemistry and microbiology; Fluorescent dye for scientific or research use; Immunohistochemistry detection kits consisting of mouse secondary reagentsDAB chromogensDAB buffersperoxidase blocking reagenthematoxylinfor anatomic pathology purposes in the medical diagnostics industry; Kit containing pre-packed columnschemicalspre-made buffer concentratessyringes and instructional manual for the purification of proteins for in vitro use; Laboratory chemicalsan antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; Nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposes; Protein arrays and nucleotide arrays for scientific and medical research; Protein in raw material form for scientific and medical research; Reagent kits comprising generic DNA circleDNA primerspolymerase and buffers for use in biotechnology fields; Reagents and substrateschemical compounds for use in patterning at nano scale or near nano scale; Reagents for research purposes; Reagents for scientific or medical research use; Reagents for use in scientific apparatus for chemical or biological analysis; Testing kits containing peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; Testing kits containing peptide substrates used in analyzing and detecting certain toxins for laboratory or research use
Publications
History of USPTO decisions and trademark events.
21 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/06/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/06/2024
E815
TEAS SECTION 8 & 15 RECEIVED
02/20/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/27/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
02/27/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/12/2017
PUBO
PUBLISHED FOR OPPOSITION
12/12/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/22/2017
ALIE
ASSIGNED TO LIE
11/05/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/25/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/24/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/24/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/24/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/29/2017
GNRT
NON-FINAL ACTION E-MAILED
09/29/2017
CNRT
NON-FINAL ACTION WRITTEN
09/29/2017
DOCK
ASSIGNED TO EXAMINER
09/29/2017
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/13/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/12/2017
NWAP
NEW APPLICATION ENTERED
07/08/2017
Continuous trademark protection
Get notified about every new filing that threatens BIOSS ANTIBODIES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.